{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:01:07Z","timestamp":1781517667390,"version":"3.54.1"},"reference-count":45,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"MSD"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2024,11,18]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to assess the prevalence of clonal haematopoiesis (CH) in patients with giant cell arteritis (GCA) compared with controls and individuals with other autoimmune diseases (AIDs) and to identify high-risk clinical\/genetic profiles that could influence disease outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In a prospective observational study at three hospitals, we included 49 patients diagnosed with GCA, 48 patients with other AIDs and 27 control participants. We used next-generation sequencing to detect clonal haematopoiesis (CH) among them.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CH was detected in 55.1% of patients with GCA, 59.3% of controls and 18.8% of patients with other AIDs. The most commonly mutated genes in GCA and control groups were <jats:italic>DNMT3A<\/jats:italic> and <jats:italic>TET2<\/jats:italic>. No significant differences in CH prevalence were found between patients with GCA and controls or other AID when adjusted for age and sex. Cluster analysis revealed two distinct groups within the patients with GCA, one of which displayed a higher prevalence of TET2 and JAK2 variants, and was associated with worse prognosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CH is prevalent among patients with GCA but does not differ significantly from controls or other autoimmune conditions. However, specific genetic profiles, particularly mutations in TET2 and JAK2, are associated with a higher risk cluster within the GCA cohort. This observation highlights the interest of detecting CH in patients with GCA in both routine practice and clinical trials for better risk stratification. Further prospective studies are needed to determine if management tailored to the genetic profile would improve outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2024-004694","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T19:26:21Z","timestamp":1733858781000},"page":"e004694","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Higher risk profile among patients with TET2-mutated giant cell arteritis: a cluster analysis"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4571-6219","authenticated-orcid":false,"given":"Alexis F","family":"Guedon","sequence":"first","affiliation":[{"name":"Institut Pierre Louis d'Epid\u00e9miologie et de Sant\u00e9 Publique, Sorbonne Universit\u00e9, Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale, Paris, France"},{"name":"Sorbonne Universit\u00e9 Service de m\u00e9decine interne, AP-HP, H\u00f4pital Saint Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Ouafdi","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Service de m\u00e9decine interne, AP-HP, H\u00f4pital Saint Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Belfeki","sequence":"additional","affiliation":[{"name":"H\u00f4pital de Melun, Service de M\u00e9decine Interne, Melun, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeddine","family":"Dellal","sequence":"additional","affiliation":[{"name":"H\u00f4pital Montfermeil, Service de M\u00e9decine Interne et Rhumatologie, Montfermeil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouha","family":"Ghriss","sequence":"additional","affiliation":[{"name":"H\u00f4pital de Melun, Service de M\u00e9decine Interne, Melun, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Scheen","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie, Gen\u00e8ve, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Haidar","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie, Gen\u00e8ve, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0821-9990","authenticated-orcid":false,"given":"Olivier","family":"Espitia","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CHU Nantes, Department of Internal and Vascular Medicine, l'institut du thorax, INSERM UMR1087\/CNRS UMR 6291, Team III Vascular & Pulmonary diseases, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Scoazec","sequence":"additional","affiliation":[{"name":"Institut Gustave-Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Fain","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Service de m\u00e9decine interne, AP-HP, H\u00f4pital Saint Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Marzac","sequence":"additional","affiliation":[{"name":"Institut Gustave-Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[{"name":"CEREMAST, Paris University, Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Solary","sequence":"additional","affiliation":[{"name":"Gustave Roussy Institute, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Rossignol","sequence":"additional","affiliation":[{"name":"Imagine Institute, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2849-3049","authenticated-orcid":false,"given":"Ars\u00e8ne","family":"Mekinian","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9 Service de m\u00e9decine interne, AP-HP, H\u00f4pital Saint Antoine, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"2025090312210581000_10.4.e004694.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715"},{"key":"2025090312210581000_10.4.e004694.2","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-021-02450-w","article-title":"A meta-analysis of the epidemiology of giant cell arteritis across time and space","volume":"23","author":"Li","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2025090312210581000_10.4.e004694.3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.0954-6820.1972.tb15615.x","article-title":"Morphological changes in the large arteries in polymyalgia arteritica","volume":"533","author":"Ostberg","year":"1972","journal-title":"Acta Med Scand Suppl"},{"key":"2025090312210581000_10.4.e004694.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.23577"},{"key":"2025090312210581000_10.4.e004694.5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200865"},{"key":"2025090312210581000_10.4.e004694.6","doi-asserted-by":"crossref","unstructured":"Gu\u00e9don AF , Froger C , Agard C , et al . Identifying Giant Cell Arteritis patients with higher risk of relapse and vascular events: a cluster analysis. QJM An Int J of Med 2024.","DOI":"10.1093\/qjmed\/hcae105"},{"key":"2025090312210581000_10.4.e004694.7","doi-asserted-by":"crossref","first-page":"ii51","DOI":"10.1093\/rheumatology\/kex423","article-title":"Pathogenesis of giant-cell arteritis: how targeted therapies are influencing our understanding of the mechanisms involved","volume":"57","author":"Terrades-Garcia","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312210581000_10.4.e004694.8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-06826-4","article-title":"Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis","volume":"7","author":"van Sleen","year":"2017","journal-title":"Sci Rep"},{"key":"2025090312210581000_10.4.e004694.9","doi-asserted-by":"publisher","DOI":"10.1002\/path.1660"},{"key":"2025090312210581000_10.4.e004694.10","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N"},{"key":"2025090312210581000_10.4.e004694.11","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCRESAHA.118.313206","article-title":"MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis","volume":"123","author":"Watanabe","year":"2018","journal-title":"Circ Res"},{"key":"2025090312210581000_10.4.e004694.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408617"},{"key":"2025090312210581000_10.4.e004694.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1701719"},{"key":"2025090312210581000_10.4.e004694.14","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4673","article-title":"Clonal hematopoiesis in human aging and disease","volume":"366","author":"Jaiswal","year":"2019","journal-title":"Science"},{"key":"2025090312210581000_10.4.e004694.15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/art.42738","article-title":"Association of Somatic TET2 Mutations With Giant Cell Arteritis","volume":"76","author":"Robinette","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2025090312210581000_10.4.e004694.16","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224933"},{"key":"2025090312210581000_10.4.e004694.17","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223480"},{"key":"2025090312210581000_10.4.e004694.18","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)61602-x"},{"key":"2025090312210581000_10.4.e004694.19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v070.i01","article-title":"missMDA : A Package for Handling Missing Values in Multivariate Data Analysis","volume":"70","author":"Josse","year":"2016","journal-title":"J Stat Soft"},{"key":"2025090312210581000_10.4.e004694.20","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/rheumatology\/keab337","article-title":"Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory study","volume":"61","author":"Papo","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312210581000_10.4.e004694.21","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/rheumatology\/kead435","article-title":"Clonal haematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls","volume":"63","author":"Salzbrunn","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312210581000_10.4.e004694.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00843-3"},{"key":"2025090312210581000_10.4.e004694.23","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015384"},{"key":"2025090312210581000_10.4.e004694.24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature15252","article-title":"Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature New Biol"},{"key":"2025090312210581000_10.4.e004694.25","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1182\/bloodadvances.2023011445","article-title":"Multiomic profiling of human clonal hematopoiesis reveals genotype and cell-specific inflammatory pathway activation","volume":"8","author":"Heimlich","year":"2024","journal-title":"Blood Adv"},{"key":"2025090312210581000_10.4.e004694.26","first-page":"737","article-title":"Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden","volume":"29","author":"Uddhammar","year":"2002","journal-title":"J Rheumatol"},{"key":"2025090312210581000_10.4.e004694.27","doi-asserted-by":"publisher","DOI":"10.1002\/art.11480"},{"key":"2025090312210581000_10.4.e004694.28","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2993"},{"key":"2025090312210581000_10.4.e004694.29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev262"},{"key":"2025090312210581000_10.4.e004694.30","first-page":"753","article-title":"Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink","volume":"56","author":"Li","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025090312210581000_10.4.e004694.31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2019.01.009","article-title":"Ischemic stroke in giant-cell arteritis: French retrospective study","volume":"99","author":"Pariente","year":"2019","journal-title":"J Autoimmun"},{"key":"2025090312210581000_10.4.e004694.32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11041005","article-title":"An Updated Review of Cardiovascular Events in Giant Cell Arteritis","volume":"11","author":"de Boysson","year":"2022","journal-title":"J Clin Med"},{"key":"2025090312210581000_10.4.e004694.33","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.14"},{"key":"2025090312210581000_10.4.e004694.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.03885.x"},{"key":"2025090312210581000_10.4.e004694.35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"The Lancet"},{"key":"2025090312210581000_10.4.e004694.36","first-page":"227","article-title":"Strokes at Time of Disease Diagnosis in a Series of 287 Patients With Biopsy-Proven Giant Cell Arteritis","volume":"88","author":"Gonzalez-Gay","year":"2009","journal-title":"Medicine (Abingdon)"},{"key":"2025090312210581000_10.4.e004694.37","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161033"},{"key":"2025090312210581000_10.4.e004694.38","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-013-2814-0"},{"key":"2025090312210581000_10.4.e004694.39","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2017.11.029","article-title":"Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients","volume":"17","author":"de Boysson","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2025090312210581000_10.4.e004694.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.06.031"},{"key":"2025090312210581000_10.4.e004694.41","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.037388"},{"key":"2025090312210581000_10.4.e004694.42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s44161-022-00206-6","article-title":"TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease","volume":"2","author":"Zekavat","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"2025090312210581000_10.4.e004694.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914"},{"key":"2025090312210581000_10.4.e004694.44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","article-title":"TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial","volume":"7","author":"Svensson","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2025090312210581000_10.4.e004694.45","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313225"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2024-004694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T19:21:19Z","timestamp":1756927279000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2024-004694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,10]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/rmdopen-2024-004694"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2024-004694","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}